Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

By Bramahn . Singh, S. Connolly, H. Crijns, D. Roy, P. Kowey, A. Capucci, D. Radzik, E. Aliot, S. Hohnloser. New England Journal of Medicine, 2007

648 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/e68b2e40e354daee354b1352ed154d2b104084f1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerhard Hindricks
2. Gregory Y. H. Lip
3. A. Goette
4. Paulus Kirchhof
5. Ulrich Schotten

Citations in the corpus

• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “2 Dronedarone Dronedarone maintains sinus rhythm, reduces ventricular rate, and prevents cardiovascular hospitalizations (mostly due to AF) and cardiovascular death in patients with paroxysmal or persistent AF or flutter who had at least one relevant cardiovascular comorbidity.(583,588,656) Dronedar”
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “pivotal trials to be superior to placebo in maintaining sinus rhythm in patients with recurrent AF.(99) Combining data from the two trials, the median time to the first episode of AF was 53”